Sign inGet started

Sklawer Andrew D

Insider CIK 1782334 · BBI President and CEO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FRTX Fresh Tracks Therapeutics, M Exercise deriv2023-10-022023-10-0455,000— $00SEC↗
FRTX Fresh Tracks Therapeutics, F Tax w/h2023-10-022023-10-0420,833$0.98 $20.4K39,269SEC↗
FRTX Fresh Tracks Therapeutics, M Exercise2023-10-022023-10-0455,000— $060,102SEC↗
FRTX Fresh Tracks Therapeutics, A Award deriv2023-01-242023-01-2655,000— $055,000SEC↗
BBI Brickell Biotech, Inc. A Award deriv2022-05-052022-05-09450,000— $0450,000SEC↗
BBI Brickell Biotech, Inc. A Award deriv2021-06-142021-06-14250,000— $0250,000SEC↗
BBI Brickell Biotech, Inc. P Buy2021-05-172021-05-1915,375$0.80 $12.3K124,625SEC↗
BBI Brickell Biotech, Inc. M Exercise deriv2021-03-162021-03-1720,000— $00SEC↗
BBI Brickell Biotech, Inc. M Exercise2021-03-162021-03-1720,000— $0116,250SEC↗
BBI Brickell Biotech, Inc. F Tax w/h2021-03-162021-03-177,000$1.14 $8.0K109,250SEC↗
BBI Brickell Biotech, Inc. A Award deriv2020-09-152020-09-16450,000— $0450,000SEC↗
BBI Brickell Biotech, Inc. P Buy deriv2020-06-222020-06-2213,044— $013,044SEC↗
BBI Brickell Biotech, Inc. P Buy2020-06-222020-06-2213,044— $096,250SEC↗
BBI Brickell Biotech, Inc. A Award deriv2020-03-162020-03-1820,000$1.54 $30.8K20,000SEC↗